Tirzepatide, a groundbreaking medication initially developed for managing type 2 diabetes, is now gaining recognition for its exceptional results in weight loss. At MOAB Texas in Trophy Club, TX, we offer this innovative therapy as part of our comprehensive weight loss programs, helping patients achieve their health and wellness goals safely and effectively.
Table of Contents
What Is Tirzepatide?
Tirzepatide is a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist. This unique mechanism sets it apart from other treatments by targeting two key hormones involved in glycemic control, appetite regulation, and weight management. Marketed under the brand name Mounjaro by Eli Lilly and Company, Tirzepatide is FDA-approved for managing type 2 diabetes and is being explored for its potential to treat obesity.
How Does Tirzepatide Work for Weight Loss?
Tirzepatide enhances the body’s ability to manage blood sugar and control body weight through its dual action:
- GLP-1 Activation: Reduces hunger, slows gastric emptying, and decreases glucagon production, stabilizing baseline glucose levels.
- GIP Synergy: Enhances fat metabolism and complements GLP-1 effects for greater weight reduction.
This approach has shown superior results in placebo-controlled trials, with some studies, such as SURMOUNT-1, reporting an average weight loss of up to 20% in patients with obesity.1
Mechanism of Action
The combined effects of GIP and GLP-1 receptors drive powerful weight-related outcomes:
- Improved Glycemic Control: Helps reduce HbA1c levels in patients with type 2 diabetes mellitus.
- Metabolic Benefits: Supports fat loss and reduces risks of cardiovascular disease.
- Sustained Appetite Suppression: Decreases calorie intake, making it ideal for chronic weight management.
What to Expect During Tirzepatide Therapy
Initial Consultation:
- Our providers will assess your body mass index (BMI), medical history, and weight loss goals to determine if Tirzepatide is right for you.
Weekly Dose Administration:
- Tirzepatide is administered as a subcutaneous injection.
- Dose escalation is gradual to ensure tolerability and minimize gastrointestinal side effects such as nausea or constipation.
Personalized Support:
- Lifestyle guidance, including a reduced-calorie diet and increased physical activity, is integrated into your plan.
Potential Side Effects
While Tirzepatide is generally well-tolerated, some patients may experience adverse events, including:
- Gastrointestinal Symptoms: Mild constipation, diarrhea, or nausea.
- Gallbladder Concerns: Rare cases of cholelithiasis or cholecystitis.
- Pancreatitis: Monitor for abdominal pain as a potential sign of pancreatic inflammation.
Patients with a history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 should avoid Tirzepatide due to potential thyroid cancer risks.
Comparison with Other Weight Loss Medications
| Medication | Mechanism | Average Weight Loss | Dosing |
| Tirzepatide | GIP/GLP-1 receptor agonist | Up to 20% | Weekly |
| Semaglutide (Wegovy) | GLP-1 receptor agonist | Up to 15% | Weekly |
| Liraglutide (Saxenda) | GLP-1 receptor agonist | 5-10% | Daily |
In randomized clinical trials, Tirzepatide demonstrated superior outcomes compared to Semaglutide and other medications, largely due to its dual mechanism.
Why Choose MOAB Texas for Tirzepatide Therapy?
At MOAB Texas, we are dedicated to delivering cutting-edge solutions like Tirzepatide to help you achieve sustainable weight loss. With personalized care and a focus on long-term success, we offer:
- Expert Guidance: Comprehensive support from consultation to follow-up.
- Tailored Plans: Customized strategies for effective weight loss and glycemic control.
- Advanced Care: Access to the latest therapies backed by clinical trials and research.
Cost and Insurance Coverage
Although not yet FDA-approved for weight loss, Tirzepatide’s proven effectiveness has led to widespread off-label use for weight-related conditions. Insurance coverage may vary, so we recommend reaching out to us to discuss costs.
Ongoing Research and Long-Term Safety
- SURMOUNT-3 and SURMOUNT-4 Trials: Ongoing studies evaluate long-term effects, including risks of weight regain post-discontinuation.
- Tolerability: Data show manageable side effects during phase 3 trials, with low rates of treatment discontinuation due to adverse events.
Frequently Asked Questions
How does Tirzepatide impact cardiovascular health?
Tirzepatide has shown benefits in reducing risks of cardiovascular disease by lowering blood pressure, improving lipid profiles, and supporting weight loss.
Can Tirzepatide be combined with other diabetes medications?
Yes, it can complement therapies like metformin, but always consult your healthcare provider for personalized guidance.
What happens if I miss a dose?
If you miss your weekly dose, take it as soon as possible within three days. After that, skip the missed dose and resume your regular schedule.
Is Tirzepatide safe for people with kidney disease?
While generally safe, patients with severe kidney disease should use caution and consult their healthcare professional before starting therapy.
- Jastreboff, Ania M., et al. “Tirzepatide Once Weekly for the Treatment of Obesity.” New England Journal of Medicine, vol. 387, no. 3, 2022, pp. 205-216. New England Journal of Medicine, doi:10.1056/NEJMoa2206038. Accessed 27 Nov. 2024. ↩︎